Table 3:

Procedural and clinical outcomes between the 2 groupsa

Total (n = 114)UK Group (MT+UK+MT) (n = 45)Non-UK Group (MT+MT) (n = 69)P Value
Onset to puncture time (min)b158 (110–413)182 (122–412)149 (102–420).561
Procedure timeb62 (42–93)54 (39–88)69 (49–113).137
Onset to reperfusion timeb253 (169–491)254 (195–481)231 (164–503).561
First-line technique.533
 SR72 (63.2)31 (68.9)41 (59.4)
 CA29 (25.4)9 (20.0)20 (29.0)
 Combined technique13 (11.4)5 (11.1)8 (11.6)
Rescue therapy78 (68.4)27 (60.0)51 (73.9).118
 Switch to SR24 (21.1)9 (20.0)15 (21.7)
 Switch to CA23 (20.2)8 (17.8)15 (21.7)
 Switch to SR+CA34 (29.8)10 (22.2)24 (34.8)
Total No. of passesb5 (5–6)6 (5–6)6 (6–7).289
 4–5 Passes49 (43.0)22 (48.9)27 (39.1).304
 6–7 Passes46 (40.4)17 (37.8)29 (42.0).651
 ≥8 Passes19 (16.7)6 (13.3)13 (18.8).441
Other adjuvant treatments22 (19.3)7 (15.6)15 (21.7).414
Final reperfusion status
 2b–381 (71.1)37 (82.2)44 (63.8).034
 328 (24.6)16 (35.6)12 (17.4).044
mRS at 90 daysb3 (2–5)3 (1–4)3 (2–5).352
mRS 0–2 at 90 days41 (36.0)17 (37.8)24 (34.8).745
Mortality at 90 days16 (14.0)7 (15.6)9 (13.0).706
Vessel perforation2 (1.8)1 (2.2)1 (1.4)1.000
Dissection5 (4.4)1 (2.2)4 (5.8).647
ICH15 (13.2)5 (11.1)10 (14.5).602
SAH7 (6.1)2 (4.4)5 (7.2).702
HI1 or HI220 (17.5)7 (15.6)13 (18.8).652
PH1 or PH28 (7.0)2 (4.4)6 (8.7).476
  • Note:—HI indicates hemorrhagic infarction; PH, parenchymatous hematoma.

  • a Values in parentheses represent the number of patients (%).

  • b Data are medians and numbers in parentheses are IQR.